
We evaluated the zzso efficacy of zzso a zzso zzso zzso during its use in 15 children with zzso disease who received zzso zzso either alone zzso or in combination zzso with other zzso zzso zzso was given to 15 children (8 boys and 7 girls, ranging from 6 months to 17 years of zzso with zzso zzso Generally, zzso (5 zzso maximum 5 zzso was administered zzso the first day of zzso chemotherapy and orally for 4 subsequent days of zzso The dose of zzso was reduced to zzso zzso in children less than 1 year of age and/or those weighing less than 10 zzso zzso and zzso were controlled completely in 8 of 15 zzso children on day 1 with a single intravenous infusion of zzso zzso control was observed in zzso of patients on day zzso Complete control of delayed zzso and vomiting ranged between zzso and zzso in patients over days 2 to zzso The results obtained during administration of zzso confirm that it is a zzso safe, and manageable zzso for the treatment of zzso disease in pediatric zzso 

